Skip to main content
. 2024 Feb 5;74:103675. doi: 10.1016/j.breast.2024.103675

Table 2.

Local treatment.

Treatment, n (%) n = 50
 In situ SRS 37 (74 %)
 In situ Observed 5 (10 %)
 Neurosurgery alone 4 (8 %)
 Cavity SRS 4 (8 %)
SRS PTVs, cc n = 41
 Mean (SD) 2.1 (3.3)
 Median [range] 0.6 [0.0–14.4]
 IQR 0.3–2.2
 Missing 1
SRS dose, n (%) n = 41
 18Gy in 1 fraction 3 (7 %)
 20Gy in 1 fraction 24 (59 %)
 22Gy in 1 fraction 4 (10 %)
 24Gy in 3 fractions 9 (22 %)
 30Gy in 5 fractions 1 (2 %)